1. Introduction
===============

Soft corals of the genus *Lobophytum* (Alcyoniidae) have been reported as a rich source of secondary metabolites endowed with a range of structural diversity and various biological activities \[[@B1-marinedrugs-10-00306],[@B2-marinedrugs-10-00306],[@B3-marinedrugs-10-00306],[@B4-marinedrugs-10-00306],[@B5-marinedrugs-10-00306],[@B6-marinedrugs-10-00306],[@B7-marinedrugs-10-00306],[@B8-marinedrugs-10-00306],[@B9-marinedrugs-10-00306],[@B10-marinedrugs-10-00306],[@B11-marinedrugs-10-00306],[@B12-marinedrugs-10-00306],[@B13-marinedrugs-10-00306],[@B14-marinedrugs-10-00306],[@B15-marinedrugs-10-00306],[@B16-marinedrugs-10-00306],[@B17-marinedrugs-10-00306],[@B18-marinedrugs-10-00306],[@B19-marinedrugs-10-00306],[@B20-marinedrugs-10-00306],[@B21-marinedrugs-10-00306],[@B22-marinedrugs-10-00306],[@B23-marinedrugs-10-00306],[@B24-marinedrugs-10-00306]\]. Previous bioassay results of some cembranoids and their analogues have demonstrated remarkable pharmacological potential such as cytotoxicity against various cancer cell lines \[[@B2-marinedrugs-10-00306],[@B3-marinedrugs-10-00306],[@B4-marinedrugs-10-00306],[@B5-marinedrugs-10-00306],[@B6-marinedrugs-10-00306],[@B7-marinedrugs-10-00306],[@B8-marinedrugs-10-00306],[@B9-marinedrugs-10-00306]\], anti-inflammatory properties \[[@B11-marinedrugs-10-00306],[@B12-marinedrugs-10-00306],[@B13-marinedrugs-10-00306]\], antimicrobial activities \[[@B11-marinedrugs-10-00306]\], and HIV-inhibitory activity \[[@B14-marinedrugs-10-00306]\]. In previous papers \[[@B2-marinedrugs-10-00306],[@B3-marinedrugs-10-00306],[@B4-marinedrugs-10-00306]\], we reported the isolation of several cytotoxic cembranolides, lobomichaolide, crassolide, and michaolides A--K from samples of the soft coral *Lobophytum michaelae* Tixier-Durivault (Alcyoniidae) ([Figure 1](#marinedrugs-10-00306-f001){ref-type="fig"}). In this report, a new specimen of the soft coral *L. michaelae* was studied since the CH~2~Cl~2~ solubles exhibited significant cytotoxity against HT-29 (human colon adenocarcinoma) and P-388 (mouse lymphocytic leukemia) cell lines as determined by standard procedures. \[[@B25-marinedrugs-10-00306],[@B26-marinedrugs-10-00306]\] Bioassay-guided fractionation of the extract resulted in the isolation of six new cembranolides, michaolides L--Q (**1**--**6**), together with the known cembranolide, lobomichaolide (**7**) \[[@B2-marinedrugs-10-00306],[@B3-marinedrugs-10-00306]\] ([Figure 2](#marinedrugs-10-00306-f002){ref-type="fig"}).

![Soft coral *Lobophytum michaelae*.](marinedrugs-10-00306-g001){#marinedrugs-10-00306-f001}

![Structures of compounds **1**--**7**.](marinedrugs-10-00306-g002){#marinedrugs-10-00306-f002}

2. Results and Discussion
=========================

Michaolide L (**1**) was isolated as a colorless oil, \[α\]~D~^25^ +13.3 (*c* 0.1, CHCl~3~). HRESIMS, ^13^C NMR, and DEPT spectroscopic data established the molecular formula of **1** as C~22~H~30~O~6~. The IR spectrum of **1** indicated the presence of the functionalities of ester group(s) (*ν*~max~ 1734 cm^−1^) and an α-methylene-γ-lactone (*ν*~max~ 1766, 1668 cm^−1^). The presence of the α-methylene-γ-lactone system in **1** was also demonstrated by UV absorption at 222 (log ε 3.68) nm and signals at δ 5.67 (H-16) and 6.44 (H-16) in the ^1^H NMR spectrum ([Table 1](#marinedrugs-10-00306-t001){ref-type="table"}). The ^1^H NMR spectrum of **1** also showed signals for two olefinic protons at δ 5.65 (H-11), and 5.19 (H-7) ppm; four oxymethine protons at δ 4.46 (t, *J* = 6.8 Hz, H-2), 2.70 (d, *J* = 6.8 Hz, H-3), 5.64 (m, H-10), and 4.38 (m, H-14); one methine proton at δ 2.90 (m, H-1), two olefinic methyl groups at δ 1.55 (H~3~-19) and 1.72 (H~3~-20); and a methyl group in acetate ester at δ 2.05. HMBC spectrum exhibited a methyl-bearing trisubstituted epoxide \[δ~H~ 2.70 (d, *J* = 6.8 Hz, H-3), 1.42(H~3~-18); δ~C~ 59.6 (CH), 64.0 (qC), 20.4 (CH~3~)\] ([Table 1](#marinedrugs-10-00306-t001){ref-type="table"}). The spectral data of **1** indicated some similarities to those of lobomichaolide (**7**) \[[@B2-marinedrugs-10-00306],[@B3-marinedrugs-10-00306]\], except for the data due to C-14. The H^1^--H^1^ COSY spectrum exhibited correlations from H-13 to H-3, H-5 to H-7, and H-9 to H-11. ^1^H--^1^H long-range correlations were also observed between H-1 to H~2~-16, H-7 to H~3~-19, and H-11 to H~3~-20. These spectroscopic findings and the nine degrees of unsaturations indicated that **1** was a 14-membered cembrane-type diterpene skeleton with an α-methylene-γ-lactone.

After assignments between all the C--H bondings were made based on an HSQC experiment, the planar structure was determined by HMBC analysis. The correlations according to HMBC are shown in [Figure 3](#marinedrugs-10-00306-f003){ref-type="fig"}. The stereochemistry for the trisubstituted olefins of **1** was determined by NOESY analysis. The NOESY correlations between H-7 and H-9, and H-11 and H-13 disclosed the *E* configurations for the trisubstituted olefins. The chemical shift values at δ~C~ 15.6 and 15.9 (for C-19 and C-20, respectively) also supported the *E* configurations \[[@B2-marinedrugs-10-00306],[@B3-marinedrugs-10-00306]\]. The NOESY correlations ([Figure 4](#marinedrugs-10-00306-f004){ref-type="fig"}) observed between H-3 and H-1/ H-11/H~3~-19, H-14 and H-1/H~3~-20, H-7 and H-9/ H-11, H-10 and H~3~-20/H~3~-19, and H~3~-18 and H-2 indicated the relative configurations for the 14-membered ring carbons, which were identical to those of lobomichaolide (**7**). Analysis of the Δδ*~S--R~* values ([Figure 5](#marinedrugs-10-00306-f005){ref-type="fig"}) according to the Mosher model pointed to an *R* configuration for C-14 of **1**, because H~2~-13, H-11, and Me-20 of (*S*)-MTPA ester **1a** were less shielded by the phenyl ring of MTPA products. Therefore, the absolute stereochemistry of Michaolide L (**1**) was established as (1*R*,2*S*,3*S*,4*R*,10*S*,14*R*,7*E*,11*E*)-10-acetoxy-14-hydroxy-3,4-epoxycembra-7,11-dien-17,2-olide ambiguously.

![COSY and HMBC correlations of compounds **1** and **2**.](marinedrugs-10-00306-g003){#marinedrugs-10-00306-f003}

marinedrugs-10-00306-t001_Table 1

###### 

^1^H and ^13^C NMR data for compounds **1**--**3**.

  Position   1                              2                             3                            
  ---------- ---------------------- ------- --------------------- ------- ---------------------------- -------
  1          2.90 m                 48.1    3.07 m                44.1    2.97 m                       45.2
  2          4.46 t (6.8) *^c^*     76.7    4.68 t (6.8)          75.2    4.52 t (6.8)                 75.3
  3          2.70 d (6.8)           59.6    2.83 d (6.8)          60.3    2.76 d (6.8)                 59.9
  4                                 64.0                          62.7                                 63.4
  5          1.91 m                 23.8    4.83 dd (10.8, 3.2)   75.5    5.05 dd (11.2, 3.6)          74.3
  6          2.03 m, 2.18 m         33.5    2.21 m, 2.42 m        30.3    2.33 m, 2.54 m               29.1
  7          5.19 br d (8.0)        129.5   5.10 t (5.6)          122.5   5.46 t (6.4)                 121.7
  8                                 127.5                         132.3                                131.3
  9          2.18 m, 2.45 m         44.7    2.38 m                44.5    5.25 br s                    75.3
  10         5.64 m                 67.8    5.67 m                68.4    2.82 m, 3.27 m               29.4
  11         5.65 m                 127.8   5.45 m                128.1   6.73 dd (9.6, 4.4)           147.0
  12                                137.5                         135.8                                137.8
  13         2.48 m, 2.91 m         44.2    2.37 m, 2.51 m        41.8    2.28 m, 2.89 m               34.7
  14         4.38 m                 68.6    5.40 m                71.1    5.77 m                       69.3
  15                                136.7                         134.9                                136.1
  16         5.67 m, 6.44 d (2.8)   122.3   5.72 s, 6.40 s        124.0   5.75 d (2.8), 6.39 d (2.8)   124.7
  17                                169.4                         168.9                                168.4
  18         1.42 s                 20.4    1.25 s                14.7    1.49 s                       15.7
  19         1.55 s                 15.6    1.66 s                16.5    1.67 s                       12.9
  20         1.72 s                 15.9    1.83 s                16.0    10.14 s                      190.3
  5-OAc                                     2.01 s                170.1   2.13 s                       170.1
                                                                  21.1                                 21.2
  9-OAc                                                                   2.13 s                       169.8
                                                                                                       20.8
  10-OAc     2.05 s                 170.5   2.05 s                170.2                                
                                    21.4                          21.2                                 
  14-OAc                                    2.11 s                170.3   2.02 s                       169.8
                                                                  21.3                                 20.5

*^a^* 400 MHz in CDCl~3~ (assigned by COSY, HSQC, and HMBC experiments); *^b^* 100 MHz in CDCl~3~ (assigned by DEPT, COSY, HSQC, and HMBC experiments); *^c^* *J* values (Hz) in parentheses.

![NOESY correlations of compounds **1** and **7**.](marinedrugs-10-00306-g004){#marinedrugs-10-00306-f004}

![Absolute stereochemistry of **1**: Δδ*~S--R~* values in ppm for MTPA esters **1a** and **1b**.](marinedrugs-10-00306-g005){#marinedrugs-10-00306-f005}

Michaolide M (**2**) was shown to have the molecular formula of C~24~H~34~O~9~ by HRESIMS and from its ^13^C NMR data. The ^1^H and ^13^C NMR spectral data ([Table 1](#marinedrugs-10-00306-t001){ref-type="table"}) of **2** closely resembled those of **7** except for the signals at C-5. ^1^H--^1^H COSY cross peak ([Figure 3](#marinedrugs-10-00306-f003){ref-type="fig"}) between H-5 and H-6/H-7 as well as HMBC correlations ([Figure 3](#marinedrugs-10-00306-f003){ref-type="fig"}) between H-5 and C-6/C-4/C-21 revealed the presence of an additional acetoxyl \[δ~H~ 4.83 (dd, *J* = 10.8, 3.2, H-5), δ~C~ 75.5 (CH, C-5), 170.1 (qC), 21.2 (CH~3~)\] at C-5 in **2**. NOESY correlations ([Figure 6](#marinedrugs-10-00306-f006){ref-type="fig"}) between H-5 and H-7, H-3 and H-1/ H-11/H~3~-19, H-14 and H-1/H~3~-20, H-7 and H-9/H-11, H-10 and H~3~-20/H~3~-19, and H~3~-18 and H-2 indicated the relative configurations for **2** resembled those of **7** except for the additional C-5 (*R*) acetoxy.

Michaolide N (**3**) analyzed for C~26~H~32~O~10~ from its HRESIMS and NMR spectroscopic data. The NMR features of compound **3** were analogous to those of **2** with exception that the secondary acetoxyl attached to C-10 was shifted to C-9 and the methyl attached to C-12 was replaced by an aldehyde \[δ~H~ 10.14, δ~C~ 190.3\] ([Table 1](#marinedrugs-10-00306-t001){ref-type="table"}). ^1^H--^1^H COSY cross peaks ([Figure 6](#marinedrugs-10-00306-f006){ref-type="fig"}) between H-9 and H-10/H-11 as well as HMBC correlations ([Figure 7](#marinedrugs-10-00306-f007){ref-type="fig"}) between H-20 and C-11/C-12/C-13 as well as between H~3~-19 and C-7/C-8/C-9 helped to ascertain these assignments. The relative stereochemistry of **3** was determined by NOESY correlations ([Figure 6](#marinedrugs-10-00306-f006){ref-type="fig"}) between H-7 and H-5/H-9/H-11, H-3 and H-1/H-11, H-14 and H-1/H-20, H-10 and H-20, H~3~-18 and H-2, and H-11 and H~2~-13.

![NOESY correlations of compounds **2** and **3**.](marinedrugs-10-00306-g006){#marinedrugs-10-00306-f006}

![COSY and HMBC correlations of compounds **3** and **4**.](marinedrugs-10-00306-g007){#marinedrugs-10-00306-f007}

Michaolide O (**4**) had the molecular formula, C~26~H~36~O~11~. Detailed comparison of the ^1^H and ^13^C NMR spectral data ([Table 2](#marinedrugs-10-00306-t002){ref-type="table"}) of **4** and **3** revealed that **4** differed from **3** at C-20 and the α-exo-methylene-γ-lactone moiety. A COSY correlation ([Figure 7](#marinedrugs-10-00306-f007){ref-type="fig"}) from H-1 to H~2~-15 and HMBC correlations ([Figure 7](#marinedrugs-10-00306-f007){ref-type="fig"}) from H~2~-15 to C-16/C-2 and from H-2 toC-17 revealed that the α-exo-methylene-γ-lactone moiety in **3** was oxidized to a formyloxyl (δ~H~ 8.27 s, δ~C~ 161.6) at C-2 and carboxylmethyl at C-1 in **4**. The relative stereochemistry of **4** was determined by NOESY correlations ([Figure 8](#marinedrugs-10-00306-f008){ref-type="fig"}) between H-7 and H-5/H-9/H-11, H-3 and H-1/H-11/H~3~-19, H-14 and H-1/H~3~-20, H~3~-18 and H-2, and H-11 and H~2~-13.

marinedrugs-10-00306-t002_Table 2

###### 

^1^H and ^13^C NMR data for compounds **4**--**6**.

  Position   4                             5                            6                              
  ---------- --------------------- ------- -------------------- ------- ------------------------------ -------
  1          2.61 m                43.2    2.68 br s            48.0    2.79 m                         46.1
  2          4.52 t (6.8)*^c^*     76.4    5.38 dd (8.8, 2.7)   73.5    5.53 dd (8.7, 6.8)             72.5
  3          2.82 d (6.8)          60.2    5.03 d (8.8)         123.3   5.18 m                         127.2
  4                                63.4                         140.0                                  140.6
  5          4.89 dd (10.8, 3.6)   75.1    2.30 m               24.1    2.33 m                         24.1
  6          2.82 m, 2.55 m        29.8    2.21 m               37.9    2.36m, 2.40 m                  33.1
  7          5.34 m                120.1   4.96 m               129.7   4.93 m                         128.8
  8                                133.5                        130.6                                  131.1
  9          5.16 m                76.6    2.32 m, 2.39 m       44.5    2.29 m, 2.40 m                 44.5
  10         2.37 m, 2.48 m        41.8    5.65 m               68.5    5.66 m                         68.0
  11         5.30 m                123.4   5.16 d (9.1)         126.6   5.19 m                         127.7
  12                               131.7                        134.5                                  136.8
  13         2.31 m, 2.68 m        43.8    2.21 m, 2.43 m       45.5    2.28 m, 2.53 m                 41.8
  14         5.32 m                69.2    4.15 m               72.9    5.28 m                         74.0
  15         3.75m, 3.85 m         35.2                         136.8                                  136.6
  16                               175.6   5.65 s, 6.41 s       122.7   5.70 s, 6.37 s                 124.4
  17         8.26 s                161.6                        167.8                                  167.3
  18         1.48 s                15.7    1.80 s               17.3    4.55 d (12.6), 4.91 d (12.6)   62.3
  19         1.60 s                12.3    1.64 s               16.7    1.61 s                         16.6
  20         1.74 s                15.6    1.75 s               16.3    1.81 s                         16.0
  5-OAc      2.11 s                170.1                                                               
                                   21.1                                                                
  9-OAc      2.11 s                170.3                                                               
                                   21.2                                                                
  10-OAc                                   2.04 s               170.0   2.01 s                         170.2
                                                                21.4                                   21.0
  14-OAc     2.12 s                170.3                                2.02 s                         170.8
                                   21.3                                                                21.3
  18-OAc                                                                2.03 s                         169.3
                                                                                                       20.9
  16-O*H*    6.18 brs                                                                                  

*^a^* 400 MHz in CDCl~3~ (assigned by COSY, HSQC, and HMBC experiments); *^b^* 100 MHz in CDCl~3~ (assigned by DEPT, COSY, HSQC, and HMBC experiments); *^c^* *J* values (Hz) in parentheses.

Michaolide P (**5**) was shown to have the molecular formula of C~22~H~30~O~5~ by HRESIMS and from its ^13^C NMR data. The ^1^H and ^13^C NMR spectral data ([Table 2](#marinedrugs-10-00306-t002){ref-type="table"}) of **5** closely resembled those of **1** except for the replacement of the trisubstituted epoxy by a trisubstituted olefin at Δ^3^. HMBC correlations ([Figure 9](#marinedrugs-10-00306-f009){ref-type="fig"}) between H~3~-18 and C-3/C-4/C-5 confirmed the presence of a trisubstituted olefin at C-3. The relative stereochemistry was determined by NOESY correlations ([Figure 8](#marinedrugs-10-00306-f008){ref-type="fig"}) between H-3 and H-1/H-11/H~3~-19, H-14 and H-1/H~3~-20, H-7 and H-9/ H-11, H-10 and H~3~-20/H~3~-19, and H~3~-18 and H-2.

![NOESY correlations of compounds **4** and **5**.](marinedrugs-10-00306-g008){#marinedrugs-10-00306-f008}

![COSY and HMBC correlations of compounds **5** and **6**.](marinedrugs-10-00306-g009){#marinedrugs-10-00306-f009}

Michaolide Q (**6**) had the molecular formula of C~26~H~34~O~8~ by HRESIMS and from its ^13^C NMR data. The ^1^H and ^13^C NMR spectroscopic data ([Table 2](#marinedrugs-10-00306-t002){ref-type="table"}) of **6** closely resembled those of **5** except for the signals at C-18 and C-14. The low field chemical shift and HMBC correlations ([Figure 9](#marinedrugs-10-00306-f009){ref-type="fig"}) between H~2~-18 and C-3/C-4/C-5/C-21 confirmed the presence of an acetoxy group at C-18. HMBC correlations ([Figure 8](#marinedrugs-10-00306-f008){ref-type="fig"}) between H-14 and C-22 revealed the presence of a second acetoxy group at C-14. The relative stereochemistry was determined by NOESY correlations between H-3 and H-1/H-11/H~3~-19, H-14 and H-1/H~3~-20, H-7 and H-9/H-11, H-10 and H~3~-20/H~3~-19, and H~3~-18 and H-2.

The cytotoxicity toward P-388 (mouse lymphocytic leukemia), HT-29 (human colon adenocarcinoma), A-549 (human lung epithelial carcinoma) tumor cells, and human embryonic lung (HEL) cells of michaolides L--Q (**1**--**6**) and lobomichaolide (**7**) were shown in [Table 3](#marinedrugs-10-00306-t003){ref-type="table"}. Non-cytotoxic cembranoid, michaolide O (**4**) was tested for anti-HCMV activity and showed a negative result (IC~50~ \> 200 μM/mL). The α-exo-methylene-γ-lactone moiety is important for cytotoxicity by comparing the cytotoxicity of **4** with those of **1**--**3**, **5**, and **6** \[[@B4-marinedrugs-10-00306]\]. The absolute stereochemistry of the known cembranolide, lobomichaolide (**7**) \[[@B2-marinedrugs-10-00306],[@B3-marinedrugs-10-00306]\] should be drawn as in [Figure 2](#marinedrugs-10-00306-f002){ref-type="fig"} since cembranolides **1** and **7** both exhibited positive optical rotations.

marinedrugs-10-00306-t003_Table 3

###### 

Cytotoxicityof **1**--**7**.

  Compounds   Cell Lines ED~50~ (μM/mL)                 
  ----------- --------------------------- ------ ------ ------
  **1**       1.2                         0.8    0.3    1.0
  **2**       2.0                         4.9    1.5    3.2
  **3**       2.1                         1.6    0.4    2.0
  **4**       61.3                        61.5   39.6   60.2
  **5**       3.2                         2.8    2.0    2.9
  **6**       2.0                         1.5    1.0    1.8
  **7**       1.9                         1.4    0.4    1.7

3. Experimental Section
=======================

3.1. General Experimental Procedures
------------------------------------

Optical rotations were determined with a JASCO P1020 digital polarimeter. Ultraviolet (UV) and infrared (IR) spectra were obtained on JASCO V-650 and JASCO FT/IR-4100 spectrophotometers, respectively. NMR spectra were recorded on a Varian MR 400 NMR spectrometer at 400 MHz for ^1^H and 100 MHz for ^13^C. ^1^H NMR chemical shifts are expressed in δ (ppm) referred to the solvent peaks δ~H~ 7.27 for CDCl~3~, and coupling constants are expressed in Hz. ^13^C NMR chemical shifts are expressed in δ (ppm) referred to the solvent peaks δ~C~ 77.0 for CDCl~3~. ESI-MS were recorded by ESI FT-MS on a Bruker APEX II mass spectrometer. Silica gel 60 (Merck, Germany, 230--400 mesh) and LiChroprep RP-18 (Merck, 40--63 μm) were used for column chromatography. Precoated silica gel plates (Merck, Kieselgel 60 F~254~, 0.25 mm) and precoated RP-18 F~254s~ plates (Merck) were used for thin-layer chromatography (TLC) analysis. High-performance liquid chromatography (HPLC) was carried out using a Hitachi L-7100 pump equipped with a Hitachi L-7400 UV detector at 220 nm together with a semi-preparative reversed-phase column (Merck, Hibar LiChrospher RP-18e, 5 μm, 250 × 25 mm).

3.2. Biological Material
------------------------

The soft coral *L. michaelae* Tixier-Durivault (Alcyoniidae) was collected at Ken-Ting, Ping-Tong County, Taiwan, in June 2002, at a depth of 3--4 m and was stored for 2 weeks in a freezer until extraction. Identification was kindly verified by Prof. Keryea Soong, Institute of Marine Biology, National Sun Yat-sen, Taiwan. A voucher specimen, MR-004, was deposited in the Department of Marine Biotechnology and Resources, National Sun Yat-sen University, Taiwan.

3.3. Extraction and Isolation
-----------------------------

The bodies of the soft coral *L. michaelae* were freeze dried to give 1.10 kg of a solid, which was extracted with CH~2~Cl~2~ (3.0 L × 3). After removal of solvent in vacuo, the residue (20 g) was chromatographed over Si gel 60 using *n*-hexane and *n*-hexane/EtOAc mixtures of increasing polarity. Elution with *n*-hexane/EtOAc (49:1) gave fractions containing **7**, with *n*-hexane/EtOAc (9:2) gave fractions containing **2** and **6**, with *n*-hexane/EtOAc (5:2) gave fractions containing **3**, with *n*-hexane/EtOAc (3:2) gave fractions containing **4**, with *n*-hexane/EtOAc (1:1) gave fractions containing **1** and **5**. Compounds **1**--**7** were further purified by RP-18 HPLC eluting with MeOH/H~2~O (50:50), MeOH/H~2~O (76:24), MeOH/H~2~O (70:30), MeOH/H~2~O (66:34), MeOH/H~2~O (50:50), MeOH/H~2~O (76:24), and MeOH/H~2~O (78:22), respectively.

Michaolide L (**1**): White amorphous powder (5 mg); \[α\]~D~^25^ +13.3 (*c* 0.1, CHCl~3~); UV λ~max~ (MeOH) nm (log ε): 222 (3.68); IR (neat) *ν*~max~ 3412, 1766, 1734, 1668 cm^−1^; ^1^H NMR (CDCl~3~, 400 MHz) and ^13^C NMR (CDCl~3~, 100 MHz) data in [Table 1](#marinedrugs-10-00306-t001){ref-type="table"}; HRESIMS *m/z* 413.1916 \[M + Na\]^+^ (calcd. for C~22~H~30~O~6~Na, 413.1914).

Preparation of Mosher's Esters of **1**. In separate NMR tubes, duplicate (1.0 mg) samples of **5** were dissolved in 0.6 mL of pyridine-*d*~5~ and allowed to react for 3 h at room temperature with (*R*)- and (*S*)-MTPA chloride (one drop) to yield (*S*)-MTPA ester **1a** and (*R*)-MTPA ester **1b**, respectively. Selected ^1^H NMR (pyridine-*d*~5~, 300 MHz) of **1a**: ^1^H NMR (CDCl~3~, 300 MHz): δ 1.35 (3H, s, H~3~-18), 1.51 (3H, s, H~3~-19), 1.98 (3H, s, H~3~-20), 2.08 (3H, s, 10-OAc), 2.32 (1H, dd, *J* = 12.1, 8.9 Hz, H-9), 2.56 (1H, d, *J* = 12.1 Hz, H-9), 2.86 (2H, m, H-13), 3.02 (1H, d, *J* = 6.1 Hz, H-3), 3.54 (3H, s, OMe), 4.57 (1H, t, *J* = 6.9 Hz, H-2), 5.22 (1H, br d, *J* = 8.2 Hz, H-7), 5.93 (1H, d, *J* = 8.4 Hz, H-11), 6.05 (1H, d, *J* = 2.8 Hz, H-16), 6.12 (1H, ddd, *J* = 10.8, 6.0, 1.5 Hz, H-14), 6.47 (1H, d, *J* = 3.2 Hz, H-16), 7.41--7.61 (5H, m, Ph). Selected ^1^H-NMR (pyridine-*d*~5~, 300 MHz) of **1b**: ^1^H NMR (CDCl~3~, 300 MHz): δ 1.37 (3H, s, H~3~-18), 1.52 (3H, s, H~3~-19), 1.97 (3H, s, H~3~-20), 2.08 (3H, s, 10-OAc), 2.32 (1H, dd, *J* = 12.3, 9.4 Hz, H-9), 2.53 (1H, d, *J* = 12.3 Hz, H-9), 2.74 (2H, m, H-13), 3.03 (1H, d, *J* = 6.8 Hz, H-3), 3.53 (3H, s, OMe), 4.69 (1H, t, *J* = 6.6 Hz, H-2), 5.20 (1H, br d, *J* = 6.9 Hz, H-7), 5.82 (1H, d, *J* = 8.8 Hz, H-11), 6.14 (1H, d, *J* = 2.2 Hz, H-16), 6.58 (1H, dd, *J* = 11.4, 3.8 Hz, H-14), 6.58 (1H, d, *J* = 3.2 Hz, H-16), 7.42--7.62 (5H, m, Ph).

Michaolide M (**2**): White amorphous powder (3 mg); \[α\]~D~^25^ +11.2 (*c* 0.1, CHCl~3~); UV λ~max~ (MeOH) nm (log ε): 221 (3.67); IR (neat) *ν*~max~ 1765, 1736, 1728, 1669 cm^−1^; ^1^H NMR (CDCl~3~, 400 MHz) and ^13^C NMR (CDCl~3~, 100 MHz) data in [Table 1](#marinedrugs-10-00306-t001){ref-type="table"}; HRESIMS *m/z* 489.2102 \[M + Na\]^+^ (calcd. for C~24~H~34~O~9~Na, 489.2101).

Michaolide N (**3**): White amorphous powder (1 mg); \[α\]~D~^25^ +7.6 (*c* 0.1, CHCl~3~); UV λ~max~ (MeOH) nm (log ε): 220 (3.76); IR (neat) *ν*~max~ 2820, 2730, 1765, 1736, 1726, 1669 cm^−1^; ^1^H NMR (CDCl~3~, 400 MHz) and ^13^C NMR (CDCl~3~, 100 MHz) data in [Table 1](#marinedrugs-10-00306-t001){ref-type="table"}; HRESIMS *m/z* 527.1885 \[M + Na\]^+^ (calcd. for C~26~H~32~O~10~Na, 527.1884).

Michaolide O (**4**): White amorphous powder (2 mg); \[α\]~D~^25^ +3.1 (*c* 0.1, CHCl~3~); IR (neat) *ν*~max~ 3420, 1740, 1731,, 1712, 1675 cm^−1^; ^1^H NMR (CDCl~3~, 400 MHz) and ^13^C NMR (CDCl~3~, 100 MHz) data in [Table 2](#marinedrugs-10-00306-t002){ref-type="table"}; HRESIMS *m/z* 547.2155 \[M + Na\]^+^ (calcd. for C~26~H~36~O~11~Na, 547.2156).

Michaolide P (**5**): White amorphous powder (1 mg); \[α\]~D~^25^ +122.0 (*c* 0.1, CHCl~3~); UV λ~max~ (MeOH) nm (log ε): 221 (3.96); IR (neat) *ν*~max~ 3450, 1765, 1735,1666 cm^−1^; ^1^H NMR (CDCl~3~, 400 MHz) and ^13^C NMR (CDCl~3~, 100 MHz) data in [Table 2](#marinedrugs-10-00306-t002){ref-type="table"}; HRESIMS *m/z* 397.1993 \[M + Na\]^+^ (calcd. for C~22~H~30~O~5~Na, 397.1992).

Michaolide Q (**6**): White amorphous powder (1 mg); \[α\]~D~^25^ +81.6 (*c* 0.1, CHCl~3~); IR (neat) *ν*~max~ 1762, 1731, 1675 cm^−1^; ^1^H NMR (CDCl~3~, 400 MHz) and ^13^C NMR (CDCl~3~, 100 MHz) data in [Table 2](#marinedrugs-10-00306-t002){ref-type="table"}; HRESIMS *m/z* 497.2154 \[M + Na\]^+^ (calcd. for C~26~H~34~O~8~Na, 497.2152).

Lobomichaolide (**7**): Colorless prism (25 mg); m.p. 180--181; \[α\]~D~^25^ +55.6 (*c* 0.1, CHCl~3~).

3.4. Cytotoxicity Assay
-----------------------

Cytotoxicity was determined on P-388 (mouse lymphocytic leukemia), HT-29 (human colon adenocarcinoma), and A-549 (human lung epithelial carcinoma) tumor cells using a modification of the MTT colorimetric method according to a previously described procedure \[[@B25-marinedrugs-10-00306],[@B26-marinedrugs-10-00306]\]. The provision of the P-388 cell line was supported by J.M. Pezzuto, formerly of the Department of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago. HT-29 and A-549 cell lines were purchased from the American Type Culture Collection.

3.5. Anti-HCMV Assay
--------------------

To determine the effects of natural products upon HCMV cytopathic effect (CPE), confluent human embryonic lung (HEL) cells grown in 24-well plates were incubated for 1 h in the presence or absence of various concentrations of tested natural products. Then, cells were infected with HCMV at an input of 1000 pfu (plaque forming units) per well of 24-well dish. Antiviral activity was expressed as IC~50~ (50% inhibitory concentration), or compound concentration required to reduce virus induced CPE by 50% after 7 days as compared with the untreated control. To monitor the cell growth upon treating with natural products, an MTT-colorimetric assay was employed \[[@B27-marinedrugs-10-00306]\].

4. Conclusion
=============

The α-exo-methylene-γ-lactone moiety is important for cytotoxicity by comparing the cytotoxicity of **4** with those of **1**--**3**, **5**, and **6** \[[@B4-marinedrugs-10-00306]\]. The absolute stereochemistry of the known cembranolide, lobomichaolide (**7**) \[[@B2-marinedrugs-10-00306],[@B3-marinedrugs-10-00306]\] should be drawn as in [Figure 2](#marinedrugs-10-00306-f002){ref-type="fig"} since cembranolides **1** and **7** both exhibited positive optical rotations.
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